was found to be highly effective in inducing changes in the intraocular pressure (IOP) and vasodilatation in the uvea in the rabbit; the reaction seems to have much in common with an axon reflex mediated by the peripheral branches of the nerve, at the endings of which some active histamine-like substance is liberated, causing pupillary contraction and intense intraocular vasodilatation. 3 Can mechanical activation of iris trigeminal nerve terminals develop naturally and contribute to meiosis seen during and between migraine attacks? Acute elevations in the IOP have been shown to discharge impulses in iris nerve fibres (and whole nerve and corneo-scleral fibres) probably due to mechanical distortion of the iris and the chamber angle4 which suggests the production of painful impulses described in experimental animals.34 An association between migraine and low-tension glaucoma (LTG) These autonomic disturbances, however, were not normally observed in the same patients. In fact, miosis was usually associated with ptosis on the symptomatic side during attacks of migraine (in darkness, r = 0-38, p < 0 001, see table 4). Since miosis persisted during the headache-free interval' 2 it seems likely that, in some cases, permanent ocular sympathetic deficit prevented greater eyelid separation on the affected side during attacks of migraine.
Discharge of the trigeminal nerve could have contributed to miosis during migraine, but this is unlikely to be the mechanism of miosis during the headache-free interval.'2 On the other hand, thermoregulatory flushing is reduced on the usual side of migraine headache,3 consistent with a decrease in cervical sympathetic outflow.4' Intraocular pressure does not increase on the symptomatic side during attacks of migraine,6 which argues against the idea that autonomic disturbances are due solely to trigeminal discharge.
Thirty years ago, Walsh and O'Doherty7 suggested that swelling of the internal carotid artery during migraine could cause ophthalmoplegia, either by direct pressure on nerves in the cavernous sinus, or by interfering with the local circulation of the involved nerves. Narrowing of the internal carotid artery, presumably due to oedema, was demonstrated by arteriography in two of three selected cases. This same process could cause cervical sympathetic deficit in migraine, because sympathetic fibres supplying the eye and skin of the forehead form a plexus around the internal carotid artery. Gray and Dean reply:
We are grateful for Dr Shepherd's comments on our study of mortality from multiple sclerosis (MS) among doctors and nurses' and for his interesting data suggesting an excess incidence of MS among doctors and nurses in North East Scotland. Dr Shepherd suggests that downward occupational drift by the time of death could explain the lack of any excess of MS deaths among doctors and nurses in our study. However, we believe this to be unlikelyparticularly for medical practitioners. The British doctors study was a prospective study and the occupation of medical practitioner was (by definition!) the necessary prerequisite to be included. Occupation was determined from the 1951 British Medical Register and not from the death certificates.
There may be three explanations for the excess incidence seen among doctors and nurses in Dr Shepherd's study. First, the methods of identifying patients2 are likely to have resulted in over-representation of doctors and nurses. To supplement the original register of patients with MS further patients were identified by visits to local hospitals and extensive surveillance of their records. A further 73 cases in this study were then identified by asking the region's GPs to note any additional cases that they knew of. As a result, nurses and doctors with MS seem more likely to be identified than those in nonmedical professions.
Second, using the 1961 census data to estimate the proportion of economically active males and females who are doctors or nurses in 1970 may have introduced some bias if the proportion who were doctors and nurses had increased over the intervening period.
Finally, doctors and nurses may have MS diagnosed earlier in the disease than other MS sufferers. Again, this "lead time" bias is likely to suggest-artefactually-that there is an excess incidence among doctors and nurses.
The sharply conflicting data from the two studies suggests that one may be biased. The lack of any excess of MS among spouses of MS patients3 indicates that MS is not (or is very rarely) a transmissible disease among adults. This observation, as well as our study, and the potential biases outlined above suggest that the incidence and mortality of MS among doctors and nurses is likely to be close to that in the general population. RICHARD effects. This type of side effect was most common in the group as a whole, and included drowsiness (five), irritability (three), anxiety (one), depression (two), emotional lability (two), confusion (one) and psychosis (one). Other side effects included weight gain (two patients) and headache (one patient).
The seven (23%) patients remaining on vigabatrin therapy have all had either a useful reduction (> 30%) in seizure frequency, and/ or significant amelioration of seizure manifestations, but none is seizure free. The starting dose of vigabatrin was reduced after the first 10 patients because seven of these patients suffered neurotropic side effects, in two cases severe. There were no severe neurotropic side effects in patients started on the lower dose of 1000 mg/day. All of our patients who showed a therapeutic response did so at a dose of 2000 mg/day or less, and there were no patients in whom increasing the dose beyond this produced any further response.
Our group of patients was different from that of Sander et al, in the type of epilepsy, and in being composed entirely ofoutpatients who may have less severe disease. We have found its therapeutic effect less good, but our experience of the neurotropic adverse effects associated with vigabatrin is similar, and we too have seen tolerance develop in a significant number ofpatients. A response rate of 23% in patients refractory to first line anticonvulsant agents is certainly worthwhile, but careful supervision is required in the early stages of therapy, and we agree with Sander et al that vigabatrin should be used with particular caution in those with a previous history of psychological problems. 
